Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer

Background: Gastric cancer (GC) is one of the most common and poor prognosis malignancy in the world. The Family with sequence similarity 83 (FAM83) comprises of eight members of A–H. Accumulating evidence confirmed important roles for FAM83 family in tumorigenesis and progression. However, the prog...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tianhao Zhang, Shurong Lai, Yuzhi Cai, Zhixin Huang, Ying Li, Sile Chen, Zhimei Zhang, Zhijun Ye, Xiaoling Lai, Ertao Zhai, Shirong Cai, Jianhui Chen
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	gastric cancer FAM83 family members prognostic biomarker lasso regression analysis nomogram prognostic model immune cell infiltration Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/faebd94abf8b4b789a7b996c528f8583
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:faebd94abf8b4b789a7b996c528f8583
record_format	dspace
spelling	oai:doaj.org-article:faebd94abf8b4b789a7b996c528f85832021-11-19T11:13:53ZComprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer2296-634X10.3389/fcell.2021.719613https://doaj.org/article/faebd94abf8b4b789a7b996c528f85832021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.719613/fullhttps://doaj.org/toc/2296-634XBackground: Gastric cancer (GC) is one of the most common and poor prognosis malignancy in the world. The Family with sequence similarity 83 (FAM83) comprises of eight members of A–H. Accumulating evidence confirmed important roles for FAM83 family in tumorigenesis and progression. However, the prognostic values of FAM83 family in GC still have not been clarified.Methods: ONCOMINE, UALCAN, GEPIA, THE HUMAN PROTEIN ATLAS, Kaplan–Meier Plotter, cBioPortal, DAVID, STRING and TIMER databases and R software were adopted in this study.Results: In this study, we demonstrated that the mRNA levels of FAM83 B/C/D/H were significantly up-regulated in stomach adenocarcinoma (STAD), but the protein level of FAM83G/H were remarkable lowly in STAD. Next, FAM83C/D/G/H were significantly associated with tumor stages in STAD patients. Then, the mutation rate of FAM83 family members in STAD patients was 46%, and the highest mutation rate was FAM83H (23%). Furthermore, the functions of FAM83 family and their 259 co-expression genes were primarily related to Shigellosis, RNA degradation and Ribosome biogenesis in eukaryotes pathway. Besides, we have established the prognostic model of FAM83 family in STAD, including the prognostic model of STAD patients (FAM83C/D/G), STAD with lymph node metastasis (FAM83C/D/G/H) and STAD with ERBB2 high expression (FAM83G/H). FAM83C/D high expression with a poor prognosis, while FAM83G/H high expression with a favorable prognosis of STAD. Additionally, we found that the expression of FAM83C/D/G/H were significantly correlated with the infiltration of six types of immune cells [B cells, CD8+T cells, CD4+T cells, macrophages and Myeloid dendritic cells (DC)], whereas CD4+T cells and Macrophage cells have higher risk scores (HR > 1) when FAM83C lowly expression and FAM83D highly expression. The risk score of NK cells was significantly reduced when FAM83G lowly expression and FAM83H highly expression (HR < 1).Conclusion: These findings suggested that FAM83C/D/G/H might play key roles in STAD tumorigenesis and progression, and FAM83C/D might be risk factors but FAM83G/H might be favorable prognostic factors for STAD patients. In addition, CD4+T cells and Macrophage cells may be the promoters of FAM83D in progression of STAD, while NK cells may promote the protective effect of FAM83H on STAD patients.Tianhao ZhangTianhao ZhangTianhao ZhangShurong LaiShurong LaiYuzhi CaiZhixin HuangZhixin HuangZhixin HuangYing LiSile ChenSile ChenZhimei ZhangZhijun YeZhijun YeXiaoling LaiXiaoling LaiErtao ZhaiErtao ZhaiShirong CaiShirong CaiJianhui ChenJianhui ChenFrontiers Media S.A.articlegastric cancerFAM83 family membersprognostic biomarkerlasso regression analysisnomogram prognostic modelimmune cell infiltrationBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	gastric cancer FAM83 family members prognostic biomarker lasso regression analysis nomogram prognostic model immune cell infiltration Biology (General) QH301-705.5
spellingShingle	gastric cancer FAM83 family members prognostic biomarker lasso regression analysis nomogram prognostic model immune cell infiltration Biology (General) QH301-705.5 Tianhao Zhang Tianhao Zhang Tianhao Zhang Shurong Lai Shurong Lai Yuzhi Cai Zhixin Huang Zhixin Huang Zhixin Huang Ying Li Sile Chen Sile Chen Zhimei Zhang Zhijun Ye Zhijun Ye Xiaoling Lai Xiaoling Lai Ertao Zhai Ertao Zhai Shirong Cai Shirong Cai Jianhui Chen Jianhui Chen Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
description	Background: Gastric cancer (GC) is one of the most common and poor prognosis malignancy in the world. The Family with sequence similarity 83 (FAM83) comprises of eight members of A–H. Accumulating evidence confirmed important roles for FAM83 family in tumorigenesis and progression. However, the prognostic values of FAM83 family in GC still have not been clarified.Methods: ONCOMINE, UALCAN, GEPIA, THE HUMAN PROTEIN ATLAS, Kaplan–Meier Plotter, cBioPortal, DAVID, STRING and TIMER databases and R software were adopted in this study.Results: In this study, we demonstrated that the mRNA levels of FAM83 B/C/D/H were significantly up-regulated in stomach adenocarcinoma (STAD), but the protein level of FAM83G/H were remarkable lowly in STAD. Next, FAM83C/D/G/H were significantly associated with tumor stages in STAD patients. Then, the mutation rate of FAM83 family members in STAD patients was 46%, and the highest mutation rate was FAM83H (23%). Furthermore, the functions of FAM83 family and their 259 co-expression genes were primarily related to Shigellosis, RNA degradation and Ribosome biogenesis in eukaryotes pathway. Besides, we have established the prognostic model of FAM83 family in STAD, including the prognostic model of STAD patients (FAM83C/D/G), STAD with lymph node metastasis (FAM83C/D/G/H) and STAD with ERBB2 high expression (FAM83G/H). FAM83C/D high expression with a poor prognosis, while FAM83G/H high expression with a favorable prognosis of STAD. Additionally, we found that the expression of FAM83C/D/G/H were significantly correlated with the infiltration of six types of immune cells [B cells, CD8+T cells, CD4+T cells, macrophages and Myeloid dendritic cells (DC)], whereas CD4+T cells and Macrophage cells have higher risk scores (HR > 1) when FAM83C lowly expression and FAM83D highly expression. The risk score of NK cells was significantly reduced when FAM83G lowly expression and FAM83H highly expression (HR < 1).Conclusion: These findings suggested that FAM83C/D/G/H might play key roles in STAD tumorigenesis and progression, and FAM83C/D might be risk factors but FAM83G/H might be favorable prognostic factors for STAD patients. In addition, CD4+T cells and Macrophage cells may be the promoters of FAM83D in progression of STAD, while NK cells may promote the protective effect of FAM83H on STAD patients.
format	article
author	Tianhao Zhang Tianhao Zhang Tianhao Zhang Shurong Lai Shurong Lai Yuzhi Cai Zhixin Huang Zhixin Huang Zhixin Huang Ying Li Sile Chen Sile Chen Zhimei Zhang Zhijun Ye Zhijun Ye Xiaoling Lai Xiaoling Lai Ertao Zhai Ertao Zhai Shirong Cai Shirong Cai Jianhui Chen Jianhui Chen
author_facet	Tianhao Zhang Tianhao Zhang Tianhao Zhang Shurong Lai Shurong Lai Yuzhi Cai Zhixin Huang Zhixin Huang Zhixin Huang Ying Li Sile Chen Sile Chen Zhimei Zhang Zhijun Ye Zhijun Ye Xiaoling Lai Xiaoling Lai Ertao Zhai Ertao Zhai Shirong Cai Shirong Cai Jianhui Chen Jianhui Chen
author_sort	Tianhao Zhang
title	Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
title_short	Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
title_full	Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
title_fullStr	Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
title_full_unstemmed	Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
title_sort	comprehensive analysis and identification of prognostic biomarkers and therapeutic targets among fam83 family members for gastric cancer
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/faebd94abf8b4b789a7b996c528f8583
work_keys_str_mv	AT tianhaozhang comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT tianhaozhang comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT tianhaozhang comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT shuronglai comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT shuronglai comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT yuzhicai comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT zhixinhuang comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT zhixinhuang comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT zhixinhuang comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT yingli comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT silechen comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT silechen comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT zhimeizhang comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT zhijunye comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT zhijunye comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT xiaolinglai comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT xiaolinglai comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT ertaozhai comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT ertaozhai comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT shirongcai comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT shirongcai comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT jianhuichen comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer AT jianhuichen comprehensiveanalysisandidentificationofprognosticbiomarkersandtherapeutictargetsamongfam83familymembersforgastriccancer
_version_	1718420171436064768

Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer

Ejemplares similares